Page last updated: 2024-10-17

choline and Asthma, Bronchial

choline has been researched along with Asthma, Bronchial in 62 studies

Research Excerpts

ExcerptRelevanceReference
"Treatment of inflammatory diseases of asthmatics can be a serious problem since some patients show intolerance to aspirin and other non-steroidal, anti-inflammatory drugs that are cyclooxygenase inhibitors."9.06Choline magnesium trisalicylate in patients with aspirin-induced asthma. ( Dworski, R; Nizankowska, E; Szczeklik, A, 1990)
"The role of the anticholinergic drug, ipratropium bromide, in maintenance antiasthmatic therapy was evaluated in a double-blind crossover trial of three bronchodilator regimens: (1) inhaled ipratropium, placebo, and oral oxtriphylline; (2) inhaled fenoterol, placebo, and oral oxtriphylline; and (3) both inhaled ipratropium and fenoterol plus oral oxtriphylline."9.05Anticholinergic and sympathomimetic combination therapy of asthma. ( Chapman, KR; Gent, M; Rebuck, AS, 1983)
"A comparison of pharmacokinetics and therapeutic effects of a standard oral theophylline preparation (Choline Theophyllinate) and controlled release aminophylline (Phyllocontin) was made in two parallel double blind trials in 25 children with chronic asthma."9.05A comparative trial of choline theophyllinate and controlled release aminophylline in chronic childhood asthma. ( Helms, P; Pearl, K; Wilson, R, 1983)
"The bioavailability of three different theophylline tablets (microcrystallinic theophylline, Theolair, Nuelin, 3M Riker), choline theophyllinate as a new film-coated tablet (Teovent, Ferrosan, Sweden) and theophyllaminopropanol (Oxyphylline, Draco, Sweden) was investigated in eight adult asthmatics and a randomized, double-blind, cross-over study."9.05Bioavailability of theophylline from three different tablets in asthmatic patients and their bronchodilating effects in combination with terbutaline inhalation. ( Mellstrand, T; Svedmyr, K; Svedmyr, N, 1982)
"Nocturnal wheeze is common in patients with asthma, and slow release theophyllines may reduce symptoms."9.05Sustained release choline theophyllinate in nocturnal asthma. ( Connaughton, JJ; Douglas, NJ; Flenley, DC; McFie, J; Rhind, GB, 1985)
" Here, the anti-inflammatory activity of choline was investigated in a mouse model of allergic airway inflammation."7.74Effect of choline chloride in allergen-induced mouse model of airway inflammation. ( Arora, N; Gaur, SN; Mehta, AK; Singh, BP, 2007)
"In eight normal and eight asthmatic subjects airway responsiveness to methacholine was measured by means of partial flow-volume loops at 0800 and 1800 hours on the same day."7.67Morning-evening changes in airway responsiveness to methacholine in normal and asthmatic subjects: analysis using partial flow-volume curves. ( Gillett, MK; Heaton, RW; Snashall, PD, 1988)
"Fifteen Chinese subjects with stable asthma were given asymmetric doses of slow-release choline theophyllinate (Theobret) according to body weight; patients under 60 kg (132 lb) received 180 mg at 9 AM and 360 mg at 9 PM for six days (period 1), followed by 180 mg at 1 PM and 360 mg at 9 PM for six days (period 2); for those over 60 kg, the regimen was the same, except that they received 270 mg during the daytime and 540 mg at night."7.67The pharmacokinetics and efficacy of slow-release theophylline with asymmetric dosing in asthmatic Chinese. ( Pang, JA; Swaminathan, R; Zhang, YG, 1988)
" On oral challenges, she developed an urticarial reaction after tartrazine; urticarial and bronchospastic reactions after salicylsalicylic acid; and urticarial and bronchospastic reactions after choline magnesium trisalicylate."7.67Sensitivity to non-acetylated salicylates in a patient with asthma, nasal polyps, and rheumatoid arthritis. ( Chudwin, DS; Frey, C; Golden, HE; Luskin, AT; Richmond, GW; Strub, M, 1986)
"We studied 16 adults with chronic bronchial asthma by measuring the plasma theophylline concentrations and evaluating clinically the control of asthma following oral administration of choline theophyllinate (CT) and a sustained-release theophylline preparation (SRT)."7.67A comparative study of the use of choline theophyllinate and a sustained-release theophylline in adults with chronic asthma. ( Chan, KW; Feng, PH; Lee, HS; Tan, TH; Ti, TY, 1985)
"Controlled standardised histamine inhalation tests were carried out in 21 asthmatics to determine the degree of non-specific bronchial hyperreactivity with and without prior treatment with several anti-asthmatic drugs."7.65Protective effect of drugs on histamine-induced asthma. ( Cockcroft, DW; Hargreave, FE; Killian, DN; Mellon, JJ, 1977)
"The treatment with choline showed significant reduction in symptom/drug score and improvement in PC(20) FEV1 compared to baseline or standard pharmacotherapy (p<0."5.36Choline attenuates immune inflammation and suppresses oxidative stress in patients with asthma. ( Arora, N; Gaur, SN; Mehta, AK; Singh, BP, 2010)
"Aspirin (ASA) and other non-steroidal anti-inflammatory drugs, which are cyclooxygenase (COX) inhibitors, precipitate asthmatic attacks in ASA-intolerant patients, while sodium salicylate, hardly active on COX by itself, is well tolerated by these patients."5.06Salicylate pre-treatment attenuates intensity of bronchial and nasal symptoms precipitated by aspirin in aspirin-intolerant patients. ( Dworski, R; Nizankowska, E; Soja, J; Szczeklik, A, 1990)
"Treatment of inflammatory diseases of asthmatics can be a serious problem since some patients show intolerance to aspirin and other non-steroidal, anti-inflammatory drugs that are cyclooxygenase inhibitors."5.06Choline magnesium trisalicylate in patients with aspirin-induced asthma. ( Dworski, R; Nizankowska, E; Szczeklik, A, 1990)
"The role of the anticholinergic drug, ipratropium bromide, in maintenance antiasthmatic therapy was evaluated in a double-blind crossover trial of three bronchodilator regimens: (1) inhaled ipratropium, placebo, and oral oxtriphylline; (2) inhaled fenoterol, placebo, and oral oxtriphylline; and (3) both inhaled ipratropium and fenoterol plus oral oxtriphylline."5.05Anticholinergic and sympathomimetic combination therapy of asthma. ( Chapman, KR; Gent, M; Rebuck, AS, 1983)
"Fifty clinically stable patients with asthma on maintenance theophylline therapy, mean dose of 15 mg kg-1 per day, were switched to an equivalent dose (X 1."5.05Study of oxtriphylline SA in 50 asthmatics. ( Bukantz, SC; Fox, RW; Lockey, RF; Samaan, SS, 1983)
"A comparison of pharmacokinetics and therapeutic effects of a standard oral theophylline preparation (Choline Theophyllinate) and controlled release aminophylline (Phyllocontin) was made in two parallel double blind trials in 25 children with chronic asthma."5.05A comparative trial of choline theophyllinate and controlled release aminophylline in chronic childhood asthma. ( Helms, P; Pearl, K; Wilson, R, 1983)
"The bioavailability of three different theophylline tablets (microcrystallinic theophylline, Theolair, Nuelin, 3M Riker), choline theophyllinate as a new film-coated tablet (Teovent, Ferrosan, Sweden) and theophyllaminopropanol (Oxyphylline, Draco, Sweden) was investigated in eight adult asthmatics and a randomized, double-blind, cross-over study."5.05Bioavailability of theophylline from three different tablets in asthmatic patients and their bronchodilating effects in combination with terbutaline inhalation. ( Mellstrand, T; Svedmyr, K; Svedmyr, N, 1982)
"Nocturnal wheeze is common in patients with asthma, and slow release theophyllines may reduce symptoms."5.05Sustained release choline theophyllinate in nocturnal asthma. ( Connaughton, JJ; Douglas, NJ; Flenley, DC; McFie, J; Rhind, GB, 1985)
"Findings will provide timely information on the safety, efficacy, and optimal dosing of t-PA to treat moderate/severe COVID-19-induced ARDS, which can be rapidly adapted to a phase III trial (NCT04357730; FDA IND 149634)."4.21 ( Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y, 2022)
" Here, the anti-inflammatory activity of choline was investigated in a mouse model of allergic airway inflammation."3.74Effect of choline chloride in allergen-induced mouse model of airway inflammation. ( Arora, N; Gaur, SN; Mehta, AK; Singh, BP, 2007)
"One immunological component of asthma is believed to be the interaction of eosinophils with parasympathetic cholinergic nerves and a consequent inhibition of acetylcholine muscarinic M2 receptor activity, leading to enhanced acetylcholine release and bronchoconstriction."3.72Eosinophil-induced release of acetylcholine from differentiated cholinergic nerve cells. ( Costello, RW; Durcan, N; Kingham, PJ; McLean, WG; Sawatzky, DA, 2003)
"The effect of two anticholinergic drugs, Ipratropium bromide, nonselective muscarinic receptor antagonist and Pirenzepine, a selective M1 receptor blocker on bronchospasm induced by metacholine and histamine was investigated."3.68[The effect of muscarinic receptor blockers on non-specific bronchial reactivity in patients with bronchial asthma]. ( Siergiejko, Z, 1992)
"In eight normal and eight asthmatic subjects airway responsiveness to methacholine was measured by means of partial flow-volume loops at 0800 and 1800 hours on the same day."3.67Morning-evening changes in airway responsiveness to methacholine in normal and asthmatic subjects: analysis using partial flow-volume curves. ( Gillett, MK; Heaton, RW; Snashall, PD, 1988)
"Fifteen Chinese subjects with stable asthma were given asymmetric doses of slow-release choline theophyllinate (Theobret) according to body weight; patients under 60 kg (132 lb) received 180 mg at 9 AM and 360 mg at 9 PM for six days (period 1), followed by 180 mg at 1 PM and 360 mg at 9 PM for six days (period 2); for those over 60 kg, the regimen was the same, except that they received 270 mg during the daytime and 540 mg at night."3.67The pharmacokinetics and efficacy of slow-release theophylline with asymmetric dosing in asthmatic Chinese. ( Pang, JA; Swaminathan, R; Zhang, YG, 1988)
" On oral challenges, she developed an urticarial reaction after tartrazine; urticarial and bronchospastic reactions after salicylsalicylic acid; and urticarial and bronchospastic reactions after choline magnesium trisalicylate."3.67Sensitivity to non-acetylated salicylates in a patient with asthma, nasal polyps, and rheumatoid arthritis. ( Chudwin, DS; Frey, C; Golden, HE; Luskin, AT; Richmond, GW; Strub, M, 1986)
"We studied 16 adults with chronic bronchial asthma by measuring the plasma theophylline concentrations and evaluating clinically the control of asthma following oral administration of choline theophyllinate (CT) and a sustained-release theophylline preparation (SRT)."3.67A comparative study of the use of choline theophyllinate and a sustained-release theophylline in adults with chronic asthma. ( Chan, KW; Feng, PH; Lee, HS; Tan, TH; Ti, TY, 1985)
"Controlled standardised histamine inhalation tests were carried out in 21 asthmatics to determine the degree of non-specific bronchial hyperreactivity with and without prior treatment with several anti-asthmatic drugs."3.65Protective effect of drugs on histamine-induced asthma. ( Cockcroft, DW; Hargreave, FE; Killian, DN; Mellon, JJ, 1977)
"The broncholytic effect and plasma concentrations of theophylline in 10 asthmatic patients were studied for 8 hours after a single dose of 600 mg choline theophyllinate in press-coated 200 mg tablets."3.65Plasma level and broncholytic effect of choline theophyllinate after a single dose of a press-coated tablet formulation. ( Bülow, KB; Larsson, H; Leideman, T, 1975)
"The treatment with choline showed significant reduction in symptom/drug score and improvement in PC(20) FEV1 compared to baseline or standard pharmacotherapy (p<0."1.36Choline attenuates immune inflammation and suppresses oxidative stress in patients with asthma. ( Arora, N; Gaur, SN; Mehta, AK; Singh, BP, 2010)
" Oxtriphylline syrup demonstrated no appreciable change in the pharmacokinetic parameter of half-life in this young age group."1.26Pharmacokinetics and taste acceptance of an alcohol-free oxtriphylline solution. ( Ellenberg, D; Ha, L; Jarboe, CH; Kadlec, GJ; Karibo, JM; Katsampes, C; Pollard, S; Simon, T; Sublett, J, 1980)

Research

Studies (62)

TimeframeStudies, this research(%)All Research%
pre-199047 (75.81)18.7374
1990's5 (8.06)18.2507
2000's4 (6.45)29.6817
2010's4 (6.45)24.3611
2020's2 (3.23)2.80

Authors

AuthorsStudies
Feng, Y1
Chang, S1
Jing, Z1
Jiang, H1
Liu, Y3
Qin, G1
Nese, M1
Riboli, G1
Brighetti, G1
Sassi, V1
Camela, E1
Caselli, G1
Sassaroli, S1
Borlimi, R1
Aucoin, M1
Cooley, K1
Saunders, PR1
Carè, J1
Anheyer, D1
Medina, DN1
Cardozo, V1
Remy, D1
Hannan, N1
Garber, A1
Velayos, M1
Muñoz-Serrano, AJ1
Estefanía-Fernández, K1
Sarmiento Caldas, MC1
Moratilla Lapeña, L1
López-Santamaría, M1
López-Gutiérrez, JC1
Li, J1
Zhang, J1
Shen, S1
Zhang, B2
Yu, WW1
Toyoda, H1
Huang, DQ1
Le, MH1
Nguyen, MH1
Huang, R1
Zhu, L1
Wang, J6
Xue, L1
Liu, L2
Yan, X2
Huang, S1
Li, Y6
Xu, T1
Li, C2
Ji, F1
Ming, F1
Zhao, Y2
Cheng, J1
Wang, Y3
Zhao, H1
Hong, S1
Chen, K2
Zhao, XA1
Zou, L1
Sang, D1
Shao, H1
Guan, X1
Chen, X2
Chen, Y4
Wei, J1
Zhu, C1
Wu, C1
Moore, HB1
Barrett, CD1
Moore, EE1
Jhunjhunwala, R1
McIntyre, RC1
Moore, PK1
Hajizadeh, N1
Talmor, DS1
Sauaia, A1
Yaffe, MB1
Liu, C3
Lin, Y1
Dong, Y1
Wu, Y1
Bao, Y1
Yan, H2
Ma, J1
Fernández-Cuadros, ME1
Albaladejo-Florín, MJ1
Álava-Rabasa, S1
Usandizaga-Elio, I1
Martinez-Quintanilla Jimenez, D1
Peña-Lora, D1
Neira-Borrajo, I1
López-Muñoz, MJ1
Rodríguez-de-Cía, J1
Pérez-Moro, OS1
Abdallah, M1
Alsaleh, H1
Baradwan, A1
Alfawares, R1
Alobaid, A1
Rasheed, A1
Soliman, I1
Wendel Garcia, PD1
Fumeaux, T1
Guerci, P1
Heuberger, DM1
Montomoli, J2
Roche-Campo, F1
Schuepbach, RA1
Hilty, MP1
Poloni, TE1
Carlos, AF1
Cairati, M1
Cutaia, C1
Medici, V1
Marelli, E1
Ferrari, D1
Galli, A1
Bognetti, P1
Davin, A1
Cirrincione, A1
Ceretti, A1
Cereda, C1
Ceroni, M1
Tronconi, L1
Vitali, S1
Guaita, A1
Leeds, JS1
Raviprakash, V1
Jacques, T1
Scanlon, N1
Cundall, J1
Leeds, CM1
Riva, A1
Gray, EH1
Azarian, S1
Zamalloa, A1
McPhail, MJW1
Vincent, RP1
Williams, R1
Chokshi, S1
Patel, VC1
Edwards, LA1
Alqarawi, W1
Birnie, DH1
Golian, M1
Nair, GM1
Nery, PB1
Klein, A1
Davis, DR1
Sadek, MM1
Neilipovitz, D1
Johnson, CB1
Green, MS1
Redpath, C1
Miller, DC1
Beamer, P1
Billheimer, D1
Subbian, V1
Sorooshian, A1
Campbell, BS1
Mosier, JM1
Novaretti, JV1
Astur, DC1
Cavalcante, ELB1
Kaleka, CC1
Amaro, JT1
Cohen, M1
Huang, W1
Li, T1
Ling, Y1
Qian, ZP1
Zhang, YY1
Huang, D1
Xu, SB1
Liu, XH1
Xia, L1
Yang, Y3
Lu, SH1
Lu, HZ1
Zhang, R2
Ma, JX1
Tang, S1
Li, CM1
Wan, J1
Wang, JF1
Ma, JQ1
Luo, JJ1
Chen, HY2
Mi, SL1
Chen, SY1
Su, YG1
Ge, JB1
Milheiro, SA1
Gonçalves, J1
Lopes, RMRM1
Madureira, M1
Lobo, L1
Lopes, A1
Nogueira, F1
Fontinha, D1
Prudêncio, M1
M Piedade, MF1
Pinto, SN1
Florindo, PR1
Moreira, R1
Castillo-Lora, J1
Delley, MF1
Laga, SM1
Mayer, JM1
Sutjarit, N1
Thongon, N1
Weerachayaphorn, J1
Piyachaturawat, P1
Suksamrarn, A1
Suksen, K1
Papachristou, DJ1
Blair, HC1
Hu, Y1
Shen, P1
Zeng, N1
Wang, L3
Yan, D1
Cui, L1
Yang, K2
Zhai, C1
Yang, M1
Lao, X1
Sun, J1
Ma, N1
Wang, S1
Ye, W1
Guo, P1
Rahimi, S1
Singh, MP1
Gupta, J1
Nakanishi, I1
Ohkubo, K1
Shoji, Y1
Fujitaka, Y1
Shimoda, K1
Matsumoto, KI1
Fukuhara, K1
Hamada, H1
van der Boom, T1
Gruppen, EG1
Lefrandt, JD1
Connelly, MA1
Links, TP1
Dullaart, RPF1
Berry, JD1
Bedlack, R1
Mathews, D1
Agnese, W1
Apple, S1
Meloncelli, S1
Divizia, M1
Germani, G1
Adefegha, SA1
Bottari, NB1
Leal, DB1
de Andrade, CM1
Schetinger, MR1
Martínez-Velasco, A1
Perez-Ortiz, AC1
Antonio-Aguirre, B1
Martínez-Villaseñor, L1
Lira-Romero, E1
Palacio-Pastrana, C1
Zenteno, JC1
Ramirez, I1
Zepeda-Palacio, C1
Mendoza-Velásquez, C1
Camacho-Ordóñez, A1
Ortiz Bibriesca, DM1
Estrada-Mena, FJ1
Martin, BL1
Thompson, LC1
Kim, YH2
Snow, SJ1
Schladweiler, MC1
Phillips, P1
Harmon, M1
King, C1
Richards, J1
George, I1
Haykal-Coates, N1
Gilmour, MI1
Kodavanti, UP1
Hazari, MS1
Farraj, AK1
Shen, Z1
Zou, Y1
Gao, K1
Lazar, S1
Wurtzel, JGT1
Ma, P1
Goldfinger, LE1
Vukelic, M1
Laloo, A1
Kyttaris, VC1
Chen, R1
Chen, J2
Xun, J1
Hu, Z1
Huang, Q2
Steinhart, C1
Shen, Y1
Lu, H1
Mansuri, A1
Lokhande, K1
Kore, S1
Gaikwad, S1
Nawani, N1
Swamy, KV1
Junnarkar, M1
Pawar, S1
Shaheen, MY1
Basudan, AM1
Niazy, AA1
van den Beucken, JJJP1
Jansen, JA1
Alghamdi, HS1
Gao, Q2
Guo, X1
Cao, Y1
Jia, X1
Xu, S1
Lu, C2
Zhu, H2
Melku, M1
Abebe, G1
Teketel, A1
Asrie, F1
Yalew, A1
Biadgo, B1
Kassa, E1
Damtie, D1
Anlay, DZ1
Ahmed, MFE1
Ramadan, H1
Seinige, D1
Kehrenberg, C1
Abd El-Wahab, A1
Volkmann, N1
Kemper, N1
Schulz, J1
Hu, MY1
Wu, YN1
McEvoy, MP1
Wang, YF1
Cong, WL1
Liu, LP1
Li, XX1
Zhou, CL1
Chen, WM1
Wei, KL1
Tung, SY1
Shen, CH1
Chang, TS1
Yen, CW1
Hsieh, YY1
Chiu, WN1
Hu, JH1
Lu, SN1
Hung, CH1
Alakavuklar, MA1
Fuqua, C1
Luo, KL1
Underwood, RS1
Greenwald, I1
Elashiry, MM1
Elashiry, M1
Zeitoun, R1
Elsayed, R1
Tian, F1
Saber, SE1
Elashry, SH1
Tay, FR1
Cutler, CW1
O'Dowd, A1
Maciel, M1
Poole, ST1
Jobling, MG1
Rollenhagen, JE1
Woods, CM1
Sincock, SA1
McVeigh, AL1
Gregory, MJ1
Maves, RC1
Prouty, MG1
Holmes, RK1
Savarino, SJ1
Mor, MK1
Palevsky, PM1
Kaufman, JS1
Thiessen Philbrook, H1
Weisbord, SD1
Parikh, CR1
John, CM1
Phillips, NJ1
Jarvis, GA1
Zhu, Y1
Kilburn, S1
Kapoor, M1
Chaturvedi, S1
Shaw, KJ1
Chaturvedi, V1
Kong, X1
Zhang, T1
Xiao, H1
Feng, X1
Tu, H1
Feng, J1
Sabet, M1
Tarazi, Z1
Griffith, DC1
Nguyen, F1
Guan, P1
Guerrero, DT1
Kolla, V1
Naraparaju, K1
Perry, LM1
Soberman, D1
Pressly, BB1
Alferiev, IS1
Chorny, M1
Brodeur, GM1
Gao, X2
Cheng, YH1
Enten, GA1
DeSantis, AJ1
Gaponenko, V1
Majetschak, M1
Kim, DY1
Choi, MJ1
Ko, TK1
Lee, NH1
Kim, OH1
Cheon, HG1
Cai, H1
Yip, V1
Lee, MV1
Wong, S1
Saad, O1
Ma, S1
Ljumanovic, N1
Khojasteh, SC1
Kamath, AV1
Shen, BQ1
Cuypers, ML1
Chanteux, H1
Gillent, E1
Bonnaillie, P1
Saunders, K1
Beckers, C1
Delatour, C1
Dell'Aiera, S1
Ungell, AL1
Nicolaï, J1
Knapp, AK1
Chen, A1
Griffin-Nolan, RJ1
Baur, LE1
Carroll, CJW1
Gray, JE1
Hoffman, AM1
Li, X4
Post, AK1
Slette, IJ1
Collins, SL1
Luo, Y1
Smith, MD1
Temitayo, GI1
Olawande, B1
Emmanuel, YO1
Timothy, AT1
Kehinde, O1
Susan, LF1
Ezra, L1
Joseph, OO1
Lev, S1
Desmarini, D1
Liuwantara, D1
Sorrell, TC1
Hawthorne, WJ1
Djordjevic, JT1
Verso, MG1
Costantino, C1
Marrella, A1
Immordino, P1
Vitale, F1
Amodio, E1
Wang, YD1
Yao, WL1
Xin, ZM1
Han, TT1
Wang, ZG1
Chen, L1
Cai, C1
Zhang, Y4
Ba, D1
Wen, S1
Tian, Q1
Lv, W1
Cheng, G1
Li, N1
Yue, XY1
Chu, WJ1
Chen, Q1
Choi, ES1
Zhao, X3
Zhou, HD1
Sun, XF1
Sharma, S2
Chhoker, S1
Xie, C1
Ong, EWY1
Tan, ZK1
Evans, S1
Weinheimer, CJ1
Kovacs, A1
Williams, JW1
Randolph, GJ1
Jiang, W1
Barger, PM1
Mann, DL1
Liu, J2
Huang, Y1
Kong, L1
Yu, X1
Feng, B1
Liu, D1
Zhao, B1
Mendes, GC1
Yuan, P1
Ge, D1
Wang, WM1
Fontes, EPB1
Li, P1
Shan, L1
He, P1
Katoh, T1
Sengoku, T1
Hirata, K1
Ogata, K1
Suga, H1
Shun, C1
Yong-Yi, J1
Mei-Li, C1
Shi-Li, L1
Jian-Bo, Z1
Dan-Li, W1
Zhi-Min, G1
Ibrahim, AM1
Zakhary, SY1
Amin, SAW1
Ugurlu, M1
Fornari, VJ1
Hartmann, MSM1
Vanni, JR1
Rodriguez, R1
Langaro, MC1
Pelepenko, LE1
Zaia, AA1
Nakanjako, D1
Zalwango, F1
Wairagala, P1
Luboga, F1
Andia Biraro, I1
Bukirwa, VD1
Mboowa, MG1
Cose, S1
Seeley, J1
Elliott, A1
Zhao, G1
Sun, P1
Hao, S1
Wang, X1
Qu, G1
Xing, Y1
Xu, X1
Maierhofer, M1
Rieger, V1
Mayr, T1
Zhang, Q1
Bigliardi, AP1
Fernandes, CLF1
Pinto, EA1
Dos Santos, M1
Garcia, EM1
Baisch, PRM1
Soares, MCF1
Muccillo-Baisch, AL1
da Silva Júnior, FMR1
Yu, W1
Ju, C1
Wang, K1
Zheng, Z1
Liu, H1
Gao, Y1
Martínez-Navarro, EM1
Cebrián-Tarancón, C1
Moratalla-López, N1
Lorenzo, C1
Alonso, GL1
Salinas, RM1
Bermúdez de Castro, JM1
Modesto-Mata, M1
Martín-Francés, L1
García-Campos, C1
Martínez de Pinillos, M1
Martinón-Torres, M1
Hasani, M1
Wu, F2
Warriner, K1
Kurz, M1
Gretzke, D1
Hörlein, R1
Turpault, S1
Atzrodt, J1
Derdau, V1
Yao, Y1
Ou, X1
Zhao, S1
Tian, B1
Jin, S1
Jiang, Z1
Zhou, Z1
Liu, M2
Jiang, GD1
Mou, LH1
Chen, JJ1
Li, ZY1
He, SG1
Reale, E1
Fustinoni, S1
Mercadante, R1
Polledri, E1
Hopf, NB1
Grant, PC1
Levy, K1
Lattimer, TA1
Depner, RM1
Kerr, CW1
Sato, J1
Merenda, MEZ1
Uemoto, AT1
Dos Santos, MP1
Barion, MRL1
Carciofi, AC1
de Paula Dorigam, JC1
Ribeiro, LB1
Vasconcellos, RS1
Waller, SB1
Peter, CM1
Hoffmann, JF1
Cleff, MB1
Faria de, RO1
Zani, JL1
Martins, BA1
Sande, D1
Solares, MD1
Takahashi, JA1
Yang, S2
Jia, Y1
Yin, C1
Zhao, R1
Ojha, M1
Wu, B1
Deepa, M1
Mo, J1
Au, DW1
Wan, MT1
Shi, J1
Zhang, G1
Winkler, C1
Kong, RY1
Seemann, F1
Bianco, M1
Calvano, CD1
Ventura, G1
Bianco, G1
Losito, I1
Cataldi, TRI1
Angiolella, L1
Staudt, A1
Duarte, PF1
Amaral, BPD1
Peixoto Andrade, BCO1
Simas, NK1
Correa Ramos Leal, I1
Sangenito, LS1
Santos, ALSD1
de Oliveira, D1
Junges, A1
Cansian, RL1
Paroul, N1
Siu, J1
Klingler, L1
Hung, CT1
Jeong, SH1
Smith, S1
Tingle, MD1
Wagner Mackenzie, B1
Biswas, K1
Douglas, RG1
Oza, AM1
Lorusso, D1
Aghajanian, C1
Oaknin, A1
Dean, A1
Colombo, N1
Weberpals, JI1
Clamp, AR1
Scambia, G1
Leary, A1
Holloway, RW1
Gancedo, MA1
Fong, PC1
Goh, JC1
O'Malley, DM1
Armstrong, DK1
Banerjee, S1
García-Donas, J1
Swisher, EM1
Cella, D1
Meunier, J1
Goble, S1
Cameron, T1
Maloney, L1
Mörk, AC1
Bedel, J1
Ledermann, JA1
Coleman, RL1
Vlek, SL1
Burm, R1
Govers, TM1
Vleugels, MPH1
Tuynman, JB1
Mijatovic, V1
Leicht, AS1
Connor, J1
Conduit, N1
Vaquera, A1
Gómez, MA1
McKay, JA1
Church, AL1
Rubin, N1
Emory, TH1
Hoven, NF1
Kuehn-Hajder, JE1
Nelson, MT1
Ramanna, S1
Auerbach, EJ1
Moeller, S1
Bolan, PJ1
Fox, NP1
Leonard, M1
Sjerps, MJ1
Chang, EF1
Hyun, S1
Saejio, A1
Shanmugam, S1
Liu, X1
Sun, M1
Bai, Z1
Jaque-Fernandez, F1
Beaulant, A1
Berthier, C1
Monteiro, L1
Allard, B1
Casas, M1
Rieusset, J1
Jacquemond, V1
Góngora-García, OR1
Aca-Aca, G1
Baz-Rodríguez, SA1
Monte, A1
Maganaris, C1
Baltzopoulos, V1
Zamparo, P1
Wang, Z2
Hou, Y1
Cai, L1
Tu, YJ1
Tan, B1
Jiang, L1
Wu, ZH1
Yu, HJ1
Li, XQ1
Yang, AD1
Titze, IR1
Palaparthi, A1
Mau, T1
González, MA1
Goiri, F1
Barandika, JF1
García-Pérez, AL1
Jatt, LP1
Gandhi, MM1
Guo, R1
Sukhija-Cohen, A1
Bhattacharya, D1
Tseng, CH1
Chew, KW1
Onwumere, J1
Pia Tek, J1
Budnyak, T1
Budnyk, S1
Karim, Z1
Thersleff, T1
Kuśtrowski, P1
Mathew, AP1
Slabon, A1
Guo, M1
Zhao, T1
Xing, Z1
Qiu, Y1
Pan, K1
Li, Z2
Zhou, W1
Ghassemi Tabrizi, S1
Arbuznikov, AV1
Jiménez-Hoyos, CA1
Kaupp, M1
Lin, MH2
Bulman, DM1
Remucal, CK1
Chaplin, BP1
Laguerre, A1
George, LA1
Gall, ET1
Emerson, MS1
Wang, H3
Maginn, EJ1
Margulis, CJ1
Li, H2
Feng, W1
Kang, X2
Yan, S1
Chao, M1
Mo, S1
Sun, W1
Lu, Y1
Chen, C1
Stevens, DM1
Adiseshaiah, P1
Dasa, SSK1
Potter, TM1
Skoczen, SL1
Snapp, KS1
Cedrone, E1
Patel, N1
Busman-Sahay, K1
Rosen, EP1
Sykes, C1
Cottrell, M1
Dobrovolskaia, MA1
Estes, JD1
Kashuba, ADM1
Stern, ST1
Özütemiz, C1
Neil, EC1
Tanwar, M1
Rubin, NT1
Ozturk, K1
Cayci, Z1
Duscha, BD1
Kraus, WE1
Jones, WS1
Robbins, JL1
Piner, LW1
Huffman, KM1
Allen, JD1
Annex, BH1
Mehmood, T1
Ahmad, I1
Bibi, S1
Mustafa, B1
Ali, I1
Dahal, RH1
Chaudhary, DK1
Kim, DU1
Kim, J2
Yeter, HH1
Gonul, I1
Guz, G1
Helvaci, O1
Korucu, B1
Akcay, OF1
Derici, U1
Arinsoy, T1
Neffati, R1
Judeinstein, P1
Rault, J1
Xu, Y1
Chai, X1
Ren, T1
Yu, S1
Fu, Q2
Ye, J1
Ge, X1
Song, J1
Yang, H2
El-Baba, TJ1
Lutomski, CA1
Kantsadi, AL1
Malla, TR1
John, T1
Mikhailov, V1
Bolla, JR1
Schofield, CJ1
Zitzmann, N1
Vakonakis, I1
Robinson, CV1
Langham, MC1
Caporale, AS1
Wehrli, FW1
Parry, S1
Schwartz, N1
den Boer, RB1
Jones, KI1
Ash, S1
van Boxel, GI1
Gillies, RS1
O'Donnell, T1
Ruurda, JP1
Sgromo, B1
Silva, MA1
Maynard, ND1
Sivieri, EM1
Eichenwald, EC1
Rub, D1
Abbasi, S1
Krahnert, I1
Bolze, A1
Gibon, Y1
Fernie, AR1
Huang, L1
Wan, Y1
Dang, Z1
Yang, P1
Yang, Q1
Wu, S2
Lin, CC1
Hsu, CT1
Liu, W2
Huang, SC1
Kortz, U1
Mougharbel, AS1
Chen, TY1
Hu, CW1
Lee, JF1
Wang, CC1
Liao, YF1
Li, LJ1
Li, L1
Peng, S1
Stimming, U1
Hebbar Kannur, K1
Yaqub, TB1
Pupier, C1
Héau, C1
Cavaleiro, A1
Yamamoto, S1
Ono, A1
Matsui, J1
Hoshino, N1
Akutagawa, T1
Miyashita, T1
Mitsuishi, M1
Patel, SM1
Smith, TG1
Morton, M1
Stiers, KM1
Seravalli, J1
Mayclin, SJ1
Edwards, TE1
Tanner, JJ1
Becker, DF1
Butcher, TW1
Yang, JL1
Hartwig, JF1
Yu, MF1
Xia, ZZ1
Yao, JC1
Feng, Z1
Li, DH1
Liu, T1
Cheng, GJ1
He, DL1
Li, XH1
Huurman, R1
Schinkel, AFL1
de Jong, PL1
van Slegtenhorst, MA1
Hirsch, A1
Michels, M1
Kataja, A1
Tarvasmäki, T1
Lassus, J1
Sionis, A1
Mebazaa, A1
Pulkki, K1
Banaszewski, M1
Carubelli, V1
Hongisto, M1
Jankowska, E1
Jurkko, R1
Jäntti, T1
Kasztura, M1
Parissis, J1
Sabell, T1
Silva-Cardoso, J1
Spinar, J1
Tolppanen, H1
Harjola, VP1
Carsetti, A1
Damiani, E1
Casarotta, E1
Scorcella, C1
Domizi, R1
Gasparri, F1
Gabbanelli, V1
Pantanetti, S1
Carozza, R1
Adrario, E1
Donati, A1
Almada, E1
Pariani, A1
Rivabella Maknis, T1
Hidalgo, F1
Vena, R1
Favre, C1
Larocca, MC1
Lu, ZY1
Jiang, WD1
Wu, P1
Kuang, SY1
Tang, L1
Yang, J1
Zhou, XQ1
Feng, L1
Leal, M1
Zampini, IC1
Mercado, MI1
Moreno, MA1
Simirgiotis, MJ1
Bórquez, J1
Ponessa, G1
Isla, MI1
Saliu, IO1
Amoo, ZA1
Khan, MF1
Olaleye, MT1
Rema, V1
Akinmoladun, AC1
Khan, AU1
Rahman, AU1
Yuan, Q1
Ahmad, A1
Khan, ZUH1
Mahnashi, MH1
Alyami, BA1
Alqahtani, YS1
Ullah, S1
Wirman, AP1
Gao, M1
Deng, L1
Zhang, K1
Wang, M1
Xia, Z1
Gao, D1
Balkissou, AD1
Poka-Mayap, V1
Massongo, M1
Djenabou, A1
Endale-Mangamba, LM1
Olomo, EJ1
Boulleys-Nana, JR1
Diffo-Sonkoue, L1
Adidigue-Ndiome, R1
Alexandra, AJE1
Haman-Wabi, AB1
Adama, S1
Iddi-Faical, A1
Pefura-Yone, EW1
Zhao, Q1
Tong, W1
Ge, C1
Zhao, D1
Norbäck, D1
Li, B1
Zhao, Z1
Huang, C1
Zhang, X1
Qian, H1
Yang, X1
Sun, Y1
Sundell, J1
Deng, Q1
Kim, HJ1
Jeon, JW1
Hwang, SM1
Chu, KI1
Cha, YH1
Kwak, YD1
Choi, SD1
Aslam, M1
Kim, CG1
Zhou, J1
Yang, E1
Yang, W1
Shrestha, SK1
Shrestha, S1
Sharma, L1
Pant, S1
Neopane, A1
Lewis, ED1
Richard, C1
Goruk, S1
Wadge, E1
Curtis, JM1
Jacobs, RL1
Field, CJ1
Bansal, P1
Saw, S1
Govindaraj, D1
Arora, N4
Kim, JS1
Son, Y1
Bae, MJ1
Lee, SS1
Park, SH1
Lee, HJ1
Lee, SI1
Lee, CG1
Kim, SD1
Jo, WS1
Kim, SH1
Shin, IS1
CURRY, JJ3
LOWELL, FC1
Mehta, AK3
Gaur, SN3
Singh, BP3
Sawatzky, DA1
Kingham, PJ1
Durcan, N1
McLean, WG1
Costello, RW1
DANN, S1
DE GRAFF, AC1
BROWN, FR1
KUPPERMAN, HS1
OTERO, JA1
MEDDA, H1
STRANG, LB1
KNOX, EG1
BLANC, P1
UNGER, DL1
TOWNLEY, RG1
BRONSTEIN, SB1
HEISEN, A1
SPIERS, AS1
AARONSON, AL1
EHRLICH, NJ1
FRANKEL, DB1
GROVER, FW1
PESET REIG, R1
LLOPIS LLOMBART, R1
LOPEZ MERINO, V1
FUCHS, JE1
LEARD, SE1
HERSCHFUS, JA1
LEVINSON, L1
GRATER, W1
McKinley, L1
Bolgos, GL1
Siddiqui, J1
Remick, DG1
SEGAL, MS1
BEAKEY, JF1
Rebuck, AS1
Gent, M1
Chapman, KR1
Fox, RW1
Samaan, SS1
Lockey, RF1
Bukantz, SC1
Morell, F1
Orriols, R1
Roca, I1
Fraile, M1
Laporte, JR1
Helms, P1
Pearl, K1
Wilson, R1
Lee, HS2
Ngiam, TE1
Eitner, L1
Wettengel, R1
Schnitker, J1
Charles, BG1
Ravenscroft, PJ1
Bochner, F1
Rudyk, BI1
Lockhart, JA1
Falliers, CJ3
Katsampes, CP1
Svedmyr, K1
Mellstrand, T1
Svedmyr, N1
Kadlec, GJ1
Jarboe, CH1
Sublett, J1
Pollard, S1
Ha, L1
Ellenberg, D1
Karibo, JM1
Simon, T1
Katsampes, C1
Konno, S1
Asano, K1
Kurokawa, M1
Ikeda, K1
Okamoto, K1
Adachi, M1
Tedeschi, A1
Cottini, M1
Salmaso, C1
Milazzo, N1
Miadonna, A1
Patterson, R2
Harris, KE2
Suszko, IM1
Roberts, M1
Cockcroft, DW1
Killian, DN1
Mellon, JJ1
Hargreave, FE1
Chodosh, S1
Baigelman, W1
Godfrey, S1
König, P1
Atkins, PC1
Norman, M1
Weiner, H1
Zweiman, B1
Bülow, KB1
Larsson, H1
Leideman, T1
Siergiejko, Z1
Nizankowska, E2
Dworski, R2
Soja, J1
Szczeklik, A2
Kiyingi, KS1
Anderson, SD1
Temple, DM1
Shaw, J1
Subramaniam, S1
Dhand, R1
Garg, SK1
Sharma, PL1
Heaton, RW1
Gillett, MK1
Snashall, PD1
Pang, JA1
Zhang, YG1
Swaminathan, R1
Chudwin, DS1
Strub, M1
Golden, HE1
Frey, C1
Richmond, GW1
Luskin, AT1
Hibberd, SG1
Alveyn, C1
Coombes, EJ1
Holgate, ST1
Rhind, GB1
Connaughton, JJ1
McFie, J1
Douglas, NJ1
Flenley, DC1
Berg, SJ1
Balant, LP1
Clarke, I1
Fairfax, AJ1
Chan, KW1
Ti, TY1
Tan, TH1
Feng, PH1
Patel, KR1
Tullett, WM1

Reviews

3 reviews available for choline and Asthma, Bronchial

ArticleYear
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
[Immunodepressive therapy in bronchial asthma (a review of the literature)].
    Vrachebnoe delo, 1981, Issue:9

    Topics: Adrenal Cortex Hormones; Asthma; Autoimmune Diseases; Choline; Heparin; Humans; Immunity; Immunosupp

1981
Inhibition of exercise-induced asthma by different pharmacological pathways.
    Thorax, 1976, Volume: 31, Issue:2

    Topics: Adolescent; Airway Obstruction; Albuterol; Asthma; Atropine Derivatives; Bronchodilator Agents; Chil

1976

Trials

17 trials available for choline and Asthma, Bronchial

ArticleYear
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
Anticholinergic and sympathomimetic combination therapy of asthma.
    The Journal of allergy and clinical immunology, 1983, Volume: 71, Issue:3

    Topics: Adolescent; Adult; Aged; Asthma; Blood Pressure; Choline; Clinical Trials as Topic; Double-Blind Met

1983
Study of oxtriphylline SA in 50 asthmatics.
    The Journal of asthma : official journal of the Association for the Care of Asthma, 1983, Volume: 20, Issue:3

    Topics: Adult; Aged; Aminophylline; Asthma; Choline; Clinical Trials as Topic; Drug Administration Schedule;

1983
A comparative trial of choline theophyllinate and controlled release aminophylline in chronic childhood asthma.
    European journal of pediatrics, 1983, Volume: 141, Issue:2

    Topics: Adolescent; Aminophylline; Asthma; Child; Choline; Chronic Disease; Double-Blind Method; Female; Hum

1983
[Comparative subacute study of the effects and side effects of a non-depot theophylline preparation (Euspirax) and a depot preparation (Euphyllin retard)--a contribution to long-term therapy of asthma].
    Praxis und Klinik der Pneumologie, 1983, Volume: 37, Issue:6

    Topics: Adolescent; Adult; Aminophylline; Asthma; Bronchodilator Agents; Choline; Delayed-Action Preparation

1983
Sustained protection with oxtriphylline-SA against allergenic bronchial challenges.
    The Journal of asthma : official journal of the Association for the Care of Asthma, 1982, Volume: 19, Issue:2

    Topics: Adult; Airway Resistance; Aminophylline; Asthma; Bronchial Provocation Tests; Bronchodilator Agents;

1982
Bioavailability of theophylline from three different tablets in asthmatic patients and their bronchodilating effects in combination with terbutaline inhalation.
    Allergy, 1982, Volume: 37, Issue:2

    Topics: Administration, Intranasal; Administration, Oral; Asthma; Biological Availability; Bronchodilator Ag

1982
Controlled assessment of beta2 adrenergic therapy for childhood asthma.
    Chest, 1978, Volume: 73, Issue:6 Suppl

    Topics: Adolescent; Adrenergic beta-Agonists; Asthma; Child; Choline; Clinical Trials as Topic; Double-Blind

1978
Bronchodilator effects of metaproterenol and oxtriphylline in asthma.
    Chest, 1978, Volume: 73, Issue:6 Suppl

    Topics: Asthma; Choline; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Forced Ex

1978
Assessment of oral antiasthmatic drugs by inhalation challenges.
    The Journal of allergy and clinical immunology, 1979, Volume: 64, Issue:6 pt 2

    Topics: Adult; Allergens; Asthma; Bronchial Provocation Tests; Choline; Clinical Trials as Topic; Double-Bli

1979
Inhibition of exercise-induced asthma by different pharmacological pathways.
    Thorax, 1976, Volume: 31, Issue:2

    Topics: Adolescent; Airway Obstruction; Albuterol; Asthma; Atropine Derivatives; Bronchodilator Agents; Chil

1976
Release of neutrophil chemotactic activity during immediate hypersensitivity reactions in humans.
    Annals of internal medicine, 1977, Volume: 86, Issue:4

    Topics: Adult; Asthma; Chemotaxis, Leukocyte; Choline; Complement System Proteins; Humans; Immunoglobulin E;

1977
Salicylate pre-treatment attenuates intensity of bronchial and nasal symptoms precipitated by aspirin in aspirin-intolerant patients.
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 1990, Volume: 20, Issue:6

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Bronchial Spasm; Choline; Double-Bl

1990
Choline magnesium trisalicylate in patients with aspirin-induced asthma.
    The European respiratory journal, 1990, Volume: 3, Issue:5

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Choline; Double-Blind Method; Drug

1990
Beta-adrenoceptor blockade with propranolol and bronchial responsiveness to a number of bronchial provocation tests in non-asthmatic subjects.
    European journal of respiratory diseases, 1985, Volume: 66, Issue:4

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Asthma; Bronchial Provocation Tests; Choline; Drug I

1985
A steady state comparison of three theophylline formulations in adult stable asthmatics.
    The Indian journal of medical research, 1988, Volume: 87

    Topics: Adult; Aminophylline; Asthma; Biological Availability; Bronchodilator Agents; Choline; Excipients; F

1988
Sustained release choline theophyllinate in nocturnal asthma.
    British medical journal (Clinical research ed.), 1985, Dec-07, Volume: 291, Issue:6509

    Topics: Adult; Aged; Asthma; Choline; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Me

1985

Other Studies

44 other studies available for choline and Asthma, Bronchial

ArticleYear
Transdermal delivery of sinapine thiocyanate by gelatin microspheres and hyaluronic acid microneedles for allergic asthma in guinea pigs.
    International journal of pharmaceutics, 2022, Jul-25, Volume: 623

    Topics: Administration, Cutaneous; Animals; Asthma; Choline; Drug Delivery Systems; Gelatin; Guinea Pigs; Hy

2022
    Journal of breath research, 2017, Sep-13, Volume: 11, Issue:4

    Topics: Adult; Animals; Animals, Newborn; Asthma; Breath Tests; Choline; Concanavalin A; Demography; Diet; E

2017
Intranasal administration of a combination of choline chloride, vitamin C, and selenium attenuates the allergic effect in a mouse model of airway disease.
    Free radical biology & medicine, 2014, Volume: 73

    Topics: Administration, Intranasal; Animals; Anti-Inflammatory Agents; Antioxidants; Ascorbic Acid; Asthma;

2014
Continuous Exposure to Low-Dose-Rate Gamma Irradiation Reduces Airway Inflammation in Ovalbumin-Induced Asthma.
    PloS one, 2015, Volume: 10, Issue:11

    Topics: Animals; Asthma; Bronchial Provocation Tests; Bronchoalveolar Lavage Fluid; Choline; Disease Models,

2015
Measurement of vital capacity in asthmatic subjects receiving histamine and acetyl-beta-methyl choline; a clinical study.
    The Journal of allergy, 1948, Volume: 19, Issue:1

    Topics: Asthma; Biomedical Research; Choline; Histamine; Humans; Tidal Volume; Vital Capacity

1948
Choline supplementation reduces oxidative stress in mouse model of allergic airway disease.
    European journal of clinical investigation, 2009, Volume: 39, Issue:10

    Topics: Administration, Inhalation; Animals; Antioxidants; Asthma; Blotting, Western; Bronchoalveolar Lavage

2009
Choline attenuates immune inflammation and suppresses oxidative stress in patients with asthma.
    Immunobiology, 2010, Volume: 215, Issue:7

    Topics: Adolescent; Adult; Asthma; Bronchial Hyperreactivity; Cells, Cultured; Choline; Cytokines; Eosinophi

2010
Eosinophil-induced release of acetylcholine from differentiated cholinergic nerve cells.
    American journal of physiology. Lung cellular and molecular physiology, 2003, Volume: 285, Issue:6

    Topics: Acetylcholine; Asthma; Cell Communication; Cell Differentiation; Cell Line, Tumor; Choline; Choliner

2003
The effective use of choline theophyllinate in the treatment of bronchial asthma and premenstrual molimina.
    International record of medicine and general practice clinics, 1954, Volume: 167, Issue:5

    Topics: Asthma; Choline; Humans; Menstruation; Theophylline

1954
[Induction of typical asthma in guinea pigs; histamine-choline synergy].
    Medicina, 1956, Volume: 16, Issue:2

    Topics: Acetylcholine; Animals; Asthma; Choline; Guinea Pigs; Histamine; Histamine Agents; Parasympathomimet

1956
Choline theophyllinate in children with asthma: a controlled trial.
    Lancet (London, England), 1960, Jan-30, Volume: 1, Issue:7118

    Topics: Asthma; Child; Choline; Humans; Theophylline

1960
[Observations on the therapeutic effect of a new bronchodilator].
    Praxis, 1962, Feb-01, Volume: 51

    Topics: Asthma; Bronchitis; Bronchodilator Agents; Choline; Humans; Pulmonary Emphysema; Quinolines; Theophy

1962
ADDITION OF GLYCERYL GUAIACOLATE TO OXTRIPHYLLINE IN CHRONIC ASTHMA: A DOUBLE BLIND STUDY.
    Annals of allergy, 1963, Volume: 21

    Topics: Asthma; Choline; Double-Blind Method; Guaifenesin; Humans; Theophylline

1963
A DOUBLE BLIND CLINICAL EVALUATION OF GLYCERYL GUAIACOLATE.
    Annals of allergy, 1963, Volume: 21

    Topics: Asthma; Bronchiectasis; Bronchitis; Choline; Cough; Double-Blind Method; Guaifenesin; Pulmonary Emph

1963
OXTRIPHYLLINE-GLYCERYL GUAIACOLATE ELIXIR AS EFFECTIVE THERAPY FOR CHRONIC BRONCHITIS AND ASTHMA.
    Journal of the American Geriatrics Society, 1964, Volume: 12

    Topics: Adolescent; Asthma; Bronchitis; Bronchitis, Chronic; Child; Choline; Geriatrics; Guaifenesin; Humans

1964
THE MANAGEMENT OF ASTHMATIC PATIENTS IN A CASUALTY DEPARTMENT.
    The Medical journal of Australia, 1964, Apr-18, Volume: 1

    Topics: Adrenal Cortex Hormones; Aminophylline; Amobarbital; Anti-Bacterial Agents; Antibiotics, Antitubercu

1964
CLINICAL EVALUATION OF BRONDECON TABLETS IN CHRONIC BRONCHIAL ASTHMA.
    Current therapeutic research, clinical and experimental, 1964, Volume: 6

    Topics: Asthma; Bronchitis; Bronchodilator Agents; Choline; Geriatrics; Guaiacol; Humans; Pulmonary Emphysem

1964
OXTRIPHYLLINE GLYCERYL GUAIACOLATE ELIXIR IN PEDIATRIC ASTHMA: WITH A THEOPHYLLINE REVIEW.
    Annals of allergy, 1965, Volume: 23

    Topics: Adolescent; Asthma; Biomedical Research; Child; Choline; Drug Therapy; Expectorants; Glycerol; Guaia

1965
[Therapeutic results obtained with Enfisin].
    Medicina espanola, 1962, Volume: 47

    Topics: Asthma; Choline; Pulmonary Emphysema; Quinolines; Theophylline; Tuberculosis; Tuberculosis, Pulmonar

1962
The effect of dihydroergocornine on the pulmonary response to methacholine and histamine in subjects with bronchial asthma.
    The Journal of clinical investigation, 1950, Volume: 29, Issue:4

    Topics: Asthma; Choline; Dihydroergocornine; Ergot Alkaloids; Histamine; Humans; Methacholine Chloride

1950
ACTH therapy in bronchial asthma; histamine and methacholine tolerance in the acute experiment and during prolonged treatment.
    Bulletin. New England Medical Center Hospital, 1950, Volume: 12, Issue:4

    Topics: Adrenocorticotropic Hormone; Asthma; Choline; Drug Tolerance; Histamine; Humans; Immune Tolerance; M

1950
EVALUATION OF A NEW HYDROALCOHOLIC BRONCHODILATOR-EXPECTORANT IN ASTHMA.
    Clinical medicine (Northfield, Ill.), 1964, Volume: 71

    Topics: Asthma; Bronchodilator Agents; Child; Choline; Expectorants; Geriatrics; Guaiacol; Respiratory Funct

1964
COMPARATIVE ACTION OF ACETYL-BETA-METHYL CHOLINE AND HISTAMINE ON THE RESPIRATORY TRACT IN NORMALS, PATIENTS WITH HAY FEVER, AND SUBJECTS WITH BRONCHIAL ASTHMA.
    The Journal of clinical investigation, 1947, Volume: 26, Issue:3

    Topics: Asthma; Choline; Histamine; Histamine Agents; Humans; Influenza, Human; Respiratory System; Rhinitis

1947
Allergens induce enhanced bronchoconstriction and leukotriene production in C5 deficient mice.
    Respiratory research, 2006, Oct-17, Volume: 7

    Topics: Acetates; Allergens; Animals; Asthma; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Choline; Co

2006
Effect of choline chloride in allergen-induced mouse model of airway inflammation.
    The European respiratory journal, 2007, Volume: 30, Issue:4

    Topics: Allergens; Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Choline; Diseas

2007
A comparative study of the action of various sympathomimetic amine aerosols in counteracting the dyspnea and bronchospasm induced by histamine and by acetyl-beta-methylcholine.
    The Journal of allergy, 1949, Volume: 20, Issue:2

    Topics: Adrenal Glands; Aerosols; Asthma; Bronchial Spasm; Choline; Dyspnea; Histamine; Histamine Agents; Me

1949
[Monitoring of plasma theophylline levels in asthmatic patients treated with oxtriphylline].
    Archivos de farmacologia y toxicologia, 1983, Volume: 9, Issue:1

    Topics: Adolescent; Adult; Aged; Asthma; Biological Availability; Child; Choline; Female; Humans; Male; Midd

1983
Plasma theophylline levels in asthmatic children in Singapore. A preliminary study.
    Singapore medical journal, 1983, Volume: 24, Issue:5

    Topics: Administration, Oral; Aminophylline; Asthma; Bronchodilator Agents; Child; Child, Preschool; Choline

1983
Comparative bioavailability study of theophylline tablets marketed in Australasia.
    The Medical journal of Australia, 1980, Sep-06, Volume: 2, Issue:5

    Topics: Absorption; Adolescent; Adult; Asthma; Biological Availability; Choline; Chromatography, High Pressu

1980
Pharmacokinetics and taste acceptance of an alcohol-free oxtriphylline solution.
    Annals of allergy, 1980, Volume: 45, Issue:4

    Topics: Asthma; Child, Preschool; Choline; Dose-Response Relationship, Drug; Ethanol; Female; Half-Life; Hum

1980
Antiasthmatic activity of a macrolide antibiotic, roxithromycin: analysis of possible mechanisms in vitro and in vivo.
    International archives of allergy and immunology, 1994, Volume: 105, Issue:3

    Topics: Animals; Antibodies; Asthma; Cells, Cultured; Choline; Cytokines; Endotoxins; Humans; Leukocytes; Li

1994
Defective inhibition of sodium on basophil histamine release in patients with allergic rhinitis and bronchial asthma.
    The European respiratory journal, 1996, Volume: 9, Issue:10

    Topics: Adult; Asthma; Basophils; Chlorides; Choline; Dose-Response Relationship, Drug; Extracellular Space;

1996
Reagin-mediated asthma in rhesus monkeys and relation to bronchial cell histamine release and airway reactivity to carbocholine.
    The Journal of clinical investigation, 1976, Volume: 57, Issue:3

    Topics: Aerosols; Animals; Antibodies; Antigens; Ascaris; Asthma; Bronchi; Choline; Disease Models, Animal;

1976
Protective effect of drugs on histamine-induced asthma.
    Thorax, 1977, Volume: 32, Issue:4

    Topics: Albuterol; Ascorbic Acid; Asthma; Atropine; Choline; Cromolyn Sodium; Female; Histamine; Humans; Ipr

1977
Arterial and muscle oxygen tension in experimental models of asthma. Experimental models of asthma.
    International archives of allergy and applied immunology, 1975, Volume: 49, Issue:3

    Topics: Animals; Antibody Formation; Ascaris; Asthma; Catheterization; Choline; Disease Models, Animal; Dogs

1975
Plasma level and broncholytic effect of choline theophyllinate after a single dose of a press-coated tablet formulation.
    European journal of clinical pharmacology, 1975, Feb-28, Volume: 8, Issue:2

    Topics: Adult; Asthma; Bronchi; Choline; Female; Forced Expiratory Volume; Humans; Isoproterenol; Kinetics;

1975
[The effect of muscarinic receptor blockers on non-specific bronchial reactivity in patients with bronchial asthma].
    Pneumonologia i alergologia polska, 1992, Volume: 60, Issue:11-12

    Topics: Adult; Asthma; Bronchial Provocation Tests; Bronchial Spasm; Choline; Female; Histamine; Humans; Ipr

1992
Morning-evening changes in airway responsiveness to methacholine in normal and asthmatic subjects: analysis using partial flow-volume curves.
    Thorax, 1988, Volume: 43, Issue:9

    Topics: Adult; Airway Resistance; Asthma; Bronchial Provocation Tests; Choline; Female; Forced Expiratory Vo

1988
The pharmacokinetics and efficacy of slow-release theophylline with asymmetric dosing in asthmatic Chinese.
    Chest, 1988, Volume: 93, Issue:4

    Topics: Adult; Asthma; Bronchodilator Agents; China; Choline; Delayed-Action Preparations; Drug Administrati

1988
Sensitivity to non-acetylated salicylates in a patient with asthma, nasal polyps, and rheumatoid arthritis.
    Annals of allergy, 1986, Volume: 57, Issue:2

    Topics: Albuterol; Arthritis, Rheumatoid; Asthma; Bronchial Spasm; Choline; Drug Combinations; Drug Hypersen

1986
Acute and chronic pharmacokinetics of asymmetrical doses of slow release choline theophyllinate in asthma.
    British journal of clinical pharmacology, 1986, Volume: 22, Issue:3

    Topics: Administration, Oral; Aged; Asthma; Blood Stains; Bronchodilator Agents; Choline; Delayed-Action Pre

1986
Slow release choline theophyllinate (Sabidal SR 270) in chronic asthma.
    British journal of clinical pharmacology, 1985, Volume: 20, Issue:1

    Topics: Adult; Asthma; Choline; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Theophylline

1985
A comparative study of the use of choline theophyllinate and a sustained-release theophylline in adults with chronic asthma.
    Annals of the Academy of Medicine, Singapore, 1985, Volume: 14, Issue:3

    Topics: Administration, Oral; Adult; Aged; Asthma; Bronchodilator Agents; Choline; Delayed-Action Preparatio

1985
Comparison of two calcium antagonists, verapamil and gallopamil (D-600), in exercise-induced asthma.
    European journal of respiratory diseases, 1985, Volume: 67, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Asthma; Blood Pressure; Choline; Forced Expiratory Volume;

1985